Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pedro Gómez-Bastar"'
Autor:
Mónica Orozco-Carroll, Ana L. Pérez-Balbuena, Oscar Olvera-Montaño, Irene M Montoya-Sánchez, Miguel A Villanueva-Najera, Pedro Gómez-Bastar, M González-Lomelí, Laura I Sandoval-Delgadillo, Mauricio Casillas-Magallanes, Aldo A Oregon-Miranda, Laura R. Saucedo-Rodríguez, Juan Carlos Ochoa-Tabares, Alfredo Mora-González, Arieh R Mercado-Sesma, Leopoldo Martín Baiza-Durán, Juan H Páez-Garza, Alfredo Lizárraga-Corona
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 34:250-255
Purpose: The purpose of this study was to evaluate the clinical efficacy and safety of a novel ophthalmic solution of pazufloxacin on the ocular surface of patients with bacterial conjunct...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9601468fcac1e476efbe8f6028b70154
https://doi.org/10.1089/jop.2017.0056
https://doi.org/10.1089/jop.2017.0056
Autor:
Leopoldo Martín, Baiza-Durán, Jaime, Alvarez-Delgado, Angélica Yussett, Contreras-Rubio, Javier, Medrano-Palafox, Anel, De Luca-Brown, Homero, Casab-Rueda, Marco Antonio, Cortés-Gastélum, Miguel Jorge, Garcidueñas-Mejía, Pedro, Gómez-Bastar, Félix, Gil-Carrasco, Curt, Hartleben-Matkin, Jesús, Jiménez-Román, Miguel Luis, Moreno-Marín, José Antonio, Paczka-Zapata, Gustavo, Velasco-Gallegos, Mario, Vergara-Sinta
Publikováno v:
Annals of ophthalmology (Skokie, Ill.). 41(3-4)
We compared the efficacy and safety of a new fixed combination of timolol 0.5%/odorzolamide 20%/brimonidine 0.2% in ophthalmic solution versus a fixed combination of timolol 0.5%/dorzolamide 2% in patients with open-angle glaucoma or ocular hypertens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0b5e0b2dabfefa8c264423956af0fa6
https://pubmed.ncbi.nlm.nih.gov/20214051
https://pubmed.ncbi.nlm.nih.gov/20214051
Autor:
Felipe Alarcon-Oceguera, Jaime R. Gonzalez, Marina Torres-Segura, Rubén Tornero-Montaño, Pedro Gómez-Bastar, Gustavo Velasco-Gallegos, Marco Beltran-Loustaunau, Jose Paczka-Zapata, Vincent Korder-Ortega, Mario I. Ortiz, Jorge Garcidueñas-Mejia, Leopoldo Martín Baiza-Durán, Marco Cortez-Gastelum, Juan D Quintana-Hau, Jesus Jimenez-Roman, Gilberto Castañeda-Hernández
Publikováno v:
Journal of clinical pharmacology. 47(1)
Recently, a new latanoprost ophthalmic solution containing cyclodextrins was developed. The purpose of the present work was to compare the stability, clinical efficacy, and adverse effect profile of this formulation with the innovator product. The in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4766e0dd16af7f4d4df7e3a74df514cc
https://pubmed.ncbi.nlm.nih.gov/18094225
https://pubmed.ncbi.nlm.nih.gov/18094225
Publikováno v:
Community Eye Health Journal, Vol 24, Iss 75, Pp 14-15 (2011)
The World Health Organization encourages the promotion and development of programmes for the prevention, detection, and management of diabetic retinopathy (DR). Such programmes must identify effective strategies and technology so that they can be ada
Externí odkaz:
https://doaj.org/article/4b335bf3b2244191803721add9e08770